FDA Delay Shows Generics Label Critics Gaining Ground
The U.S. Food and Drug Administration's upcoming hearing on a proposal to give generics makers more control over warning labels marks another delay for the rule, and attorneys say the agency's...To view the full article, register now.
Already a subscriber? Click here to view full article